Enrolling by invitationNot applicableNCT07526428
Investigating the DNN Noise Reduction Feature in Phonak Hearing Aids Using Ecological Momentary Assessment
Studying Epilepsy with eyelid myoclonia
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- Sonova AG
- Intervention
- Phonak Audeo Infinio Hearing Aid(device)
- Enrollment
- 21 target
- Eligibility
- 18 years · All sexes
- Timeline
- 2026 – 2026
Study locations (1)
- Phonak Audiology Research Center, Aurora, Illinois, United States
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT07526428 on ClinicalTrials.govOther trials for Epilepsy with eyelid myoclonia
Additional recruiting or active studies for the same condition.
- RECRUITINGNANCT07535541A Feasibility Study of Biometric Measurements Via Wearable Smart Watch Technology for Evaluation of Vasomotor Symptoms in Patients Treated With Androgen Deprivation Therapy for Prostate Cancer (Prostate 007)University of Virginia
- RECRUITINGNANCT07506148Group-Based Acceptance and Commitment Therapy Versus Active Control in University Students With Emotional SymptomsMónica Larrosa Signorelli
- RECRUITINGNANCT06906926Harmony TPV EMEA PMSMedtronic Cardiovascular
- RECRUITINGPHASE2NCT06401538BMB-101 in Absence Epilepsy and DEEBright Minds Biosciences Pty Ltd
- ACTIVE NOT RECRUITINGNCT02337244Zimmer POLAR Persona - TKA (EMEA Study)Zimmer, GmbH